Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta.

MLA

Komuro, Iwao, et al. “Erythromycin Derivatives Inhibit HIV-1 Replication in Macrophages through Modulation of MAPK Activity to Induce Small Isoforms of C/EBPbeta.” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 34, Aug. 2008, pp. 12509–14. EBSCOhost, https://doi.org/10.1073/pnas.0805504105.

APA

Komuro, I., Sunazuka, T., Akagawa, K. S., Yokota, Y., Iwamoto, A., & Omura, S. (2008). Erythromycin derivatives inhibit HIV-1 replication in macrophages through modulation of MAPK activity to induce small isoforms of C/EBPbeta. Proceedings of the National Academy of Sciences of the United States of America, 105(34), 12509–12514. https://doi.org/10.1073/pnas.0805504105

Chicago

Komuro, Iwao, Toshiaki Sunazuka, Kiyoko S Akagawa, Yasuko Yokota, Aikichi Iwamoto, and Satoshi Omura. 2008. “Erythromycin Derivatives Inhibit HIV-1 Replication in Macrophages through Modulation of MAPK Activity to Induce Small Isoforms of C/EBPbeta.” Proceedings of the National Academy of Sciences of the United States of America 105 (34): 12509–14. doi:10.1073/pnas.0805504105.